BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4967296)

  • 1. [Chemotherapy of tuberculosis--its prerequists, possibilities and limitations].
    Heymer A; Schwabe KH
    Internist (Berl); 1966 Oct; 7(10):502-9. PubMed ID: 4967296
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of failures of chemotherapy of pulmonary tuberculosis in adults].
    Anastasatu C; Mihăilescu P; Gartner A; Bogdănescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(3):153-8. PubMed ID: 229540
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemo-antibiotic resis tance and clinicoradiologic patterns of the disease in patients with chronic pulmonary tuberculosis].
    Giura R
    G Ital Mal Torace; 1967; 21(4):205-9. PubMed ID: 4970415
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
    Zozuliak VI
    Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of bronchial lesions in pulmonary tuberculosis with primary drug resistance of Mycobacteria].
    Fedotova ZN; Shesterina MV
    Probl Tuberk; 1978 Aug; (8):31-4. PubMed ID: 100778
    [No Abstract]   [Full Text] [Related]  

  • 10. [Psychosocial risk factors in pulmonary tuberculosis and the phenomenon of drug resistance in its treatment].
    Pecyna MB
    Wiad Lek; 1988 Jan; 41(1):1-8. PubMed ID: 3136589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of drug resistance of Mycobacterium tuberculosis].
    Terentieva AS
    Vrach Delo; 1979 Mar; (3):28-30. PubMed ID: 109992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Several current problems in chemotherapy of tuberculosis].
    Moisescu V
    Ftiziologia; 1973; 22(3):225-37. PubMed ID: 4197127
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-resistant tuberculosis.
    Iseman MD; Madsen LA
    Clin Chest Med; 1989 Sep; 10(3):341-53. PubMed ID: 2505962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages].
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of the frequency of development of drug resistance in the causative agent of tuberculosis and its effect on the efficacy of treatment of patients with pulmonary tuberculosis].
    Abramovskaia AK; Antipova SI
    Probl Tuberk; 1988; (10):24-7. PubMed ID: 3148132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary resistance of the tubercle bacillus to antibiotics. Bacteriological and therapeutic study. Apropos of 22 cases].
    Weill G; Levy A; Guignon JP; Petion G; Lecoq H
    Strasb Med; 1965 Mar; 16(3):165-93. PubMed ID: 4953251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.